184 related articles for article (PubMed ID: 38791449)
41. Retroviral cyclin enhances cyclin-dependent kinase-8 activity.
Rovnak J; Brewster CD; Quackenbush SL
J Virol; 2012 May; 86(10):5742-51. PubMed ID: 22379099
[TBL] [Abstract][Full Text] [Related]
42. CDK8 as a therapeutic target for cancers and recent developments in discovery of CDK8 inhibitors.
Xi M; Chen T; Wu C; Gao X; Wu Y; Luo X; Du K; Yu L; Cai T; Shen R; Sun H
Eur J Med Chem; 2019 Feb; 164():77-91. PubMed ID: 30594029
[TBL] [Abstract][Full Text] [Related]
43. Comparative genomics of cyclin-dependent kinases suggest co-evolution of the RNAP II C-terminal domain and CTD-directed CDKs.
Guo Z; Stiller JW
BMC Genomics; 2004 Sep; 5():69. PubMed ID: 15380029
[TBL] [Abstract][Full Text] [Related]
44. A complex molecular switch directs stress-induced cyclin C nuclear release through SCF
Stieg DC; Willis SD; Ganesan V; Ong KL; Scuorzo J; Song M; Grose J; Strich R; Cooper KF
Mol Biol Cell; 2018 Feb; 29(3):363-375. PubMed ID: 29212878
[TBL] [Abstract][Full Text] [Related]
45. Control of cyclin C levels during development of Dictyostelium.
Greene DM; Hsu DW; Pears CJ
PLoS One; 2010 May; 5(5):e10543. PubMed ID: 20479885
[TBL] [Abstract][Full Text] [Related]
46. Cdk8 and Ssn801 Regulate Oxidative Stress Resistance and Virulence in Cryptococcus neoformans.
Chang AL; Kang Y; Doering TL
mBio; 2019 Feb; 10(1):. PubMed ID: 30755515
[No Abstract] [Full Text] [Related]
47. Inhibition of Cyclin-Dependent Kinase 8/Cyclin-Dependent Kinase 19 Suppresses Its Pro-Oncogenic Effects in Prostate Cancer.
Offermann A; Joerg V; Becker F; Roesch MC; Kang D; Lemster AL; Tharun L; Behrends J; Merseburger AS; Culig Z; Sailer V; Brägelmann J; Kirfel J; Perner S
Am J Pathol; 2022 May; 192(5):813-823. PubMed ID: 35181333
[TBL] [Abstract][Full Text] [Related]
48. The cyclin-dependent kinase 8 module sterically blocks Mediator interactions with RNA polymerase II.
Elmlund H; Baraznenok V; Lindahl M; Samuelsen CO; Koeck PJ; Holmberg S; Hebert H; Gustafsson CM
Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15788-93. PubMed ID: 17043218
[TBL] [Abstract][Full Text] [Related]
49. Cyclin-dependent kinase 8 positively cooperates with Mediator to promote thyroid hormone receptor-dependent transcriptional activation.
Belakavadi M; Fondell JD
Mol Cell Biol; 2010 May; 30(10):2437-48. PubMed ID: 20231357
[TBL] [Abstract][Full Text] [Related]
50. Mediator can regulate mitotic entry and direct periodic transcription in fission yeast.
Banyai G; Lopez MD; Szilagyi Z; Gustafsson CM
Mol Cell Biol; 2014 Nov; 34(21):4008-18. PubMed ID: 25154415
[TBL] [Abstract][Full Text] [Related]
51. Regulation of cyclin-dependent kinase 5 catalytic activity by phosphorylation.
Sharma P; Sharma M; Amin ND; Albers RW; Pant HC
Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11156-60. PubMed ID: 10500146
[TBL] [Abstract][Full Text] [Related]
52. The role of mediator subunit 12 in tumorigenesis and cancer therapeutics.
Gonzalez CG; Akula S; Burleson M
Oncol Lett; 2022 Mar; 23(3):74. PubMed ID: 35111243
[TBL] [Abstract][Full Text] [Related]
53. CDK8: a positive regulator of transcription.
Galbraith MD; Donner AJ; Espinosa JM
Transcription; 2010; 1(1):4-12. PubMed ID: 21327159
[TBL] [Abstract][Full Text] [Related]
54. Cyclin C/CDK8 and cyclin H/CDK7/p36 are biochemically distinct CTD kinases.
Rickert P; Corden JL; Lees E
Oncogene; 1999 Jan; 18(4):1093-102. PubMed ID: 10023686
[TBL] [Abstract][Full Text] [Related]
55. CDK8 expression in 470 colorectal cancers in relation to beta-catenin activation, other molecular alterations and patient survival.
Firestein R; Shima K; Nosho K; Irahara N; Baba Y; Bojarski E; Giovannucci EL; Hahn WC; Fuchs CS; Ogino S
Int J Cancer; 2010 Jun; 126(12):2863-73. PubMed ID: 19790197
[TBL] [Abstract][Full Text] [Related]
56. Discovery and Development of Cyclin-Dependent Kinase 8 Inhibitors.
Lv X; Tian Y; Li S; Cheng K; Huang X; Kong H; Liao C; Xie Z
Curr Med Chem; 2020; 27(32):5429-5443. PubMed ID: 30947649
[TBL] [Abstract][Full Text] [Related]
57. Drosophila Cdk8, a kinase partner of cyclin C that interacts with the large subunit of RNA polymerase II.
Leclerc V; Tassan JP; O'Farrell PH; Nigg EA; Léopold P
Mol Biol Cell; 1996 Apr; 7(4):505-13. PubMed ID: 8730095
[TBL] [Abstract][Full Text] [Related]
58. Viral transactivators E1A and VP16 interact with a large complex that is associated with CTD kinase activity and contains CDK8.
Gold MO; Tassan JP; Nigg EA; Rice AP; Herrmann CH
Nucleic Acids Res; 1996 Oct; 24(19):3771-7. PubMed ID: 8871557
[TBL] [Abstract][Full Text] [Related]
59. TFIIH is negatively regulated by cdk8-containing mediator complexes.
Akoulitchev S; Chuikov S; Reinberg D
Nature; 2000 Sep; 407(6800):102-6. PubMed ID: 10993082
[TBL] [Abstract][Full Text] [Related]
60. Mediator cyclin-dependent kinases upregulate transcription of inflammatory genes in cooperation with NF-κB and C/EBPβ on stimulation of Toll-like receptor 9.
Yamamoto S; Hagihara T; Horiuchi Y; Okui A; Wani S; Yoshida T; Inoue T; Tanaka A; Ito T; Hirose Y; Ohkuma Y
Genes Cells; 2017 Mar; 22(3):265-276. PubMed ID: 28151579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
